software and biotechnology sectors. It links institutional constraints to poor performance of
German firms in high volume market niches characterized by turbulent technological change
and substantial financial risk. However, German firms are prospering in software services
and “platform technologies” in biotechnology. The company organizational structures and
investment strategies needed to excel in these market segments provide a close “fit” with …